| Sources | Names Used |
|---|---|
| GDSC1000 | KIN001-260 |
| PharmacoGx | KIN001-260 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RASA2 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | DAGLB | GDSC1000 | pan-cancer | AAC | -0.053 | 0.09 |
| mRNA | LHX3 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.09 |
| mRNA | IL4I1 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | CITED2 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | PLCB4 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | C15orf40 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | CARD16 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | ALK | GDSC1000 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | ELMO3 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.09 |
